IL326458A - Genetically modified bacteria for multi-modal secretion of a neoantigen - Google Patents
Genetically modified bacteria for multi-modal secretion of a neoantigenInfo
- Publication number
- IL326458A IL326458A IL326458A IL32645826A IL326458A IL 326458 A IL326458 A IL 326458A IL 326458 A IL326458 A IL 326458A IL 32645826 A IL32645826 A IL 32645826A IL 326458 A IL326458 A IL 326458A
- Authority
- IL
- Israel
- Prior art keywords
- secretion
- neoantigen
- bacteria
- tumor
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001154—Enzymes
- A61K39/001162—Kinases, e.g. Raf or Src
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01147—ADP-specific glucokinase (2.7.1.147)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363533275P | 2023-08-17 | 2023-08-17 | |
| US202463556139P | 2024-02-21 | 2024-02-21 | |
| PCT/IB2024/058038 WO2025037284A2 (en) | 2023-08-17 | 2024-08-19 | Genetically modified bacteria for multi-modal secretion of a neoantigen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326458A true IL326458A (en) | 2026-04-01 |
Family
ID=92800621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326458A IL326458A (en) | 2023-08-17 | 2024-08-19 | Genetically modified bacteria for multi-modal secretion of a neoantigen |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4761753A2 (de) |
| CN (1) | CN121985958A (de) |
| IL (1) | IL326458A (de) |
| WO (1) | WO2025037284A2 (de) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7842289B2 (en) | 2003-12-24 | 2010-11-30 | Aduro Biotech | Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof |
| US8357373B2 (en) | 2005-10-04 | 2013-01-22 | Ludwig Institute For Cancer Research | Methods for stimulating an immune response using bacterial antigen delivery system |
| EP1921149A1 (de) | 2006-11-13 | 2008-05-14 | AEterna Zentaris GmbH | Mikroorganismen als Träger von Nukleotidsequenzen, die für Antigene und Toxine kodieren, Verfahren zur Herstellung und deren Verwendungen |
| EA201890868A1 (ru) * | 2015-11-19 | 2018-12-28 | Университет Базель | Бактерии с ослабленной вирулентностью для лечения злокачественных солидных опухолей |
| IL295726A (en) * | 2022-08-17 | 2024-03-01 | Yeda res & development co ltd | Genetically modified bacteria for generating vaccines |
-
2024
- 2024-08-19 EP EP24772411.5A patent/EP4761753A2/de active Pending
- 2024-08-19 IL IL326458A patent/IL326458A/en unknown
- 2024-08-19 CN CN202480060775.XA patent/CN121985958A/zh active Pending
- 2024-08-19 WO PCT/IB2024/058038 patent/WO2025037284A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025037284A2 (en) | 2025-02-20 |
| WO2025037284A3 (en) | 2025-03-27 |
| CN121985958A (zh) | 2026-05-05 |
| EP4761753A2 (de) | 2026-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA215098S (en) | Serving robot | |
| GB2610546B (en) | Multifunctional auxiliary nursing robot | |
| GB2631667B (en) | Multi-layer nursing garment | |
| GB2638641B (en) | Patient interface | |
| CA219137S (en) | Nightstand | |
| EP4559634B1 (de) | Roboter | |
| GB201909082D0 (en) | Methods for control of a bioprocess | |
| EP4549108A4 (de) | Servierroboter | |
| GB202318068D0 (en) | Patient interface | |
| CA3301285A1 (en) | Genetically modified bacteria for multi-modal secretion of a neoantigen | |
| GB202117520D0 (en) | Method of underwater bonding | |
| IL310370A (en) | Inhibitors of protein expression | |
| GB202208238D0 (en) | Casket | |
| EP4093422A4 (de) | Verwendung von anti-aging-glycopeptiden zur hemmung des immunabstosses eines transplantats | |
| CA245282S (en) | Elbow for patient interface | |
| EP4559636B1 (de) | Roboter | |
| CA225227S (en) | Patient interface | |
| CA223631S (en) | Surgical robot | |
| IL316781A (en) | Flexible facility configurations for medical product manufacturing | |
| GB202020562D0 (en) | Antagnoist of LA(A) | |
| CA228709S (en) | Wheelchair | |
| CA228708S (en) | Wheelchair | |
| CA228710S (en) | Wheelchair | |
| CA228707S (en) | Wheelchair | |
| CA225388S (en) | Adhering assembly for a patient care assembly |